Back to 
BlackRock, Inc.
BlackRock, Inc.
RXRX7 quarters
Position history for BlackRock, Inc.'s holdings in RECURSION PHARMACEUTICALS IN
BlackRock, Inc. holds 50.3M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $184.6M as of 2026-Q2. The position was increased (+16.5% shares). RXRX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$184.6M
Current Shares
50.3M
Total Value Change
+$26.2M
Total Shares Change
+26.9M
Quarter-by-Quarter History
Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC